Update: Metacognition in Psychotic Disorders: Grounds for Therapy?

In 2014, my collaborators and I published a post on Mindwise entitled: “What are you thinking right now? On the topic of metacognition”, in which we discussed what metacognition is considered to be (‘thinking about thinking’) and how metacognition may play a role in different kinds of psychopathology. In this post, we seek to delve a little deeper by applying the model to disorders in the psychosis spectrum.

Read More

An Example of Blurry Boundaries

In a recent literature review my co-authors and I compared the symptoms and causes of schizophrenia spectrum disorders and dissociative disorders. The results show the limitations of categorical models of psychopathology (e.g. DSM-5) compared to models that view symptoms as extremes of normal behavior, and models emphasizing that symptoms can cause other symptoms.

Read More

HoeGekIs.NL – How Nuts Are The Dutch?

HoeGekIsNL is a national crowdsourcing study designed to create an empirically based representation of mental strengths and vulnerabilities and their role in mental disorders. It is an initiative of the Interdisciplinary Center Psychopathology and Emotion regulation (ICPE), UMCG. The team behind the project is led by professor Peter de Jonge and is comprised of scientists from different fields, including psychiatric epidemiology, psychology, computer science, and mathematics.

Read More

Psychology starts 5 new international master’s tracks

In September 2016, the Department of Psychology starts five new international master’s tracks. These tracks link psychological knowledge to particular fields of application, to prepare students in the best possible way for the job market in their respective fields. All tracks seem promising, but how do you pick the track that is right for you?

Read More

Social behaviour and serotonin:

Some unexpected findings

While an acute decrease in brain serotonin may have few effects on social behaviour, a longer-term increase in serotonin in individuals at risk for depression improves mood and alters social behaviour. This Thursday, February 4, 2016, Koen Hogenelst defends his dissertation, in which he explains the relevance of his research findings for the effectiveness of serotonergic medications for depression.

Read More